
AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

